| 臺大學術典藏 |
2022-01-12T07:07:20Z |
Incorporation of mutations in five genes in the revised International Prognostic Scoring System can improve risk stratification in the patients with myelodysplastic syndrome
|
HSIN-AN HOU; Tsai C.-H.; Lin C.-C.; Chou W.-C.; Kuo Y.-Y.; Liu C.-Y.; Tseng M.-H.; Peng Y.-L.; Liu M.-C.; Liu C.-W.; Liao X.-W.; Lin L.-I.; Yao M.; Tang J.-L.; Tien H.-F. |
| 臺大學術典藏 |
2022-01-12T07:07:19Z |
Hyperleukocytosis is associated with distinct genetic alterations and is an independent poor-risk factor in de novo acute myeloid leukemia patients
|
Tien F.-M.; HSIN-AN HOU; Tsai C.-H.; Tang J.-L.; Chen C.-Y.; Kuo Y.-Y.; Li C.-C.; Lin C.-T.; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2022-01-12T07:07:18Z |
GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemia
|
Tien F.-M.; HSIN-AN HOU; Tsai C.-H.; Tang J.-L.; Chiu Y.-C.; Chen C.-Y.; Kuo Y.-Y.; Tseng M.-H.; Peng Y.-L.; Liu M.-C.; Liu C.-W.; Liao X.-W.; Lin L.-I.; Lin C.-T.; Wu S.-J.; Ko B.-S.; Hsu S.-C.; Huang S.-Y.; Yao M.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2022-01-12T07:07:17Z |
Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA
|
Tien F.-M.; HSIN-AN HOU; Tang J.-L.; Kuo Y.-Y.; Chen C.-Y.; Tsai C.-H.; Yao M.; Lin C.-T.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Liu J.-H.; Chou S.-C.; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2022-01-12T07:07:16Z |
Clinically validated machine learning algorithm for detecting residual diseases with multicolor flow cytometry analysis in acute myeloid leukemia and myelodysplastic syndrome
|
Ko B.-S.; Wang Y.-F.; Li J.-L.; Li C.-C.; Weng P.-F.; Hsu S.-C.; HSIN-AN HOU; Huang H.-H.; Yao M.; Lin C.-T.; Liu J.-H.; Tsai C.-H.; Huang T.-C.; Wu S.-J.; Huang S.-Y.; Chou W.-C.; Tien H.-F.; Lee C.-C.; Tang J.-L. |
| 臺大學術典藏 |
2022-01-12T07:07:15Z |
Incorporation of long non-coding RNA expression profile in the 2017 ELN risk classification can improve prognostic prediction of acute myeloid leukemia patients
|
Tsai C.-H.; Yao C.-Y.; Tien F.-M.; Tang J.-L.; Kuo Y.-Y.; Chiu Y.-C.; Lin C.-C.; Tseng M.-H.; Peng Y.-L.; Liu M.-C.; Liu C.-W.; Yao M.; Lin L.-I.; Chou W.-C.; Chen C.-Y.; HSIN-AN HOU; Tien H.-F. |
| 臺大學術典藏 |
2022-01-12T07:07:14Z |
Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome
|
Huang H.-H.; Chen F.-Y.; Chou W.-C.; HSIN-AN HOU; Ko B.-S.; Lin C.-T.; Tang J.-L.; Li C.-C.; Yao M.; Tsay W.; Hsu S.-C.; Wu S.-J.; Chen C.-Y.; Huang S.-Y.; Tseng M.-H.; Tien H.-F.; Chen R.-H. |
| 臺大學術典藏 |
2022-01-12T07:07:14Z |
Adoptive donor immunity protects against resolved hepatitis B virus reactivation after allogeneic haematopoietic stem cell transplantation in the world's largest retrospective cohort study
|
Liu J.-H.; Liao X.-W.; Chen C.-H.; Yao M.; Li C.-C.; Lin C.-T.; Tsai C.-H.; Chou W.-C.; HSIN-AN HOU; Huang S.-Y.; Wu S.-J.; Chen Y.-C.; Tien H.-F.; Tang J.-L.; Ko B.-S. |
| 臺大學術典藏 |
2022-01-12T07:07:12Z |
Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclax
|
Wang Y.-W.; Tsai C.-H.; Lin C.-C.; Tien F.-M.; Chen Y.-W.; Lin H.-Y.; Yao M.; Lin Y.-C.; Lin C.-T.; Cheng C.-L.; Tang J.-L.; Chou W.-C.; HSIN-AN HOU; Tien H.-F. |
| 臺大學術典藏 |
2022-01-12T07:07:11Z |
ASXL1 mutation confers poor prognosis in primary myelofibrosis patients with low JAK2V617F allele burden but not in those with high allele burden
|
Wang Y.-H.; Lin C.-C.; Lee S.-H.; Tsai C.-H.; Wu S.-J.; HSIN-AN HOU; Huang T.-C.; Kuo Y.-Y.; Yao M.; Chang K.; Lin C.-W.; Lin Y.-C.; Tien F.-M.; Chou W.-C.; Tang J.-L.; Tien H.-F. |
| 臺大學術典藏 |
2022-01-12T07:07:10Z |
Distinct clinico-biological features in AML patients with low allelic ratio FLT3-ITD: role of allogeneic stem cell transplantation in first remission
|
Tien F.-M.; Tsai C.-H.; Huang S.-C.; Liu J.-H.; Chen C.-Y.; Kuo Y.-Y.; Chuang Y.-K.; Tseng M.-H.; Peng Y.-L.; Liu M.-C.; Liu C.-W.; Liao X.-W.; Lin L.-I.; Wu Y.-S.; Hou M.-F.; Wu S.-J.; Hsu S.-C.; Ko B.-S.; Chou W.-C.; Yao M.; HSIN-AN HOU; Tang J.-L.; Tien H.-F. |
| 臺大學術典藏 |
2022-01-12T07:07:09Z |
Polatuzumab vedotin–based salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience
|
Wang Y.-W.; Tsai X.C.-H.; HSIN-AN HOU; Tien F.-M.; Liu J.-H.; Chou W.-C.; Ko B.-S.; Chen Y.-W.; Lin C.-C.; Cheng C.-L.; Lo M.-Y.; Lin Y.-C.; Lu L.-C.; Wu S.-J.; Kuo S.-H.; Hong R.-L.; Huang T.-C.; Yao M. |
| 臺大學術典藏 |
2022-01-12T07:07:07Z |
Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML
|
Tsai C.-H.; Tang J.-L.; Tien F.-M.; Kuo Y.-Y.; Wu D.-C.; Lin C.-C.; Tseng M.-H.; Peng Y.-L.; Hou M.-F.; Chuang Y.-K.; Liu M.-C.; Liu C.-W.; Yao M.; Lin L.-I.; Chou W.-C.; Chen C.-Y.; HSIN-AN HOU; Tien H.-F. |
| 國家衛生研究院 |
2022 |
Distinct immunogenetic profiles of chronic lymphocytic leukemia in Asia: A Taiwan Cooperative Oncology Group Registry Study
|
Yao, CY;Agathangelidis, A;Chuang, SS;Tsou, HH;Feng, WL;Liu, TC;Chen, TY;Yu, YB;Yeh, SP;Yao, M;Wang, CC;Lin, J;Hwang, WL;Gau, JP;Chou, WC;Chao, TY;Lin, LI;Tien, HF;Ghia, P;Wu, SJ |
| 國立成功大學 |
2022 |
Incidence and predictors of idiopathic pneumonia syndrome in hematopoietic stem cell transplant patients: a nationwide registry study
|
Liu, M.A.;Lee, C.-C.;Phung, Q.;Dao, Q.-L.;Tehrani, B.;Yao, M.;Li, C.-C.;Wu, K.-H.;Chen, T.-C.;Gau, J.-P.;Li, S.-S.;Wang, P.-N.;Liu, Y.-C.;Wang, T.-F.;Chiou, L.-W.;Lee, M.-Y.;Yu, M.-S.;Wang, C.-C.;Lin, S.-C.;Chen, Y.-C.;Chao, T.-Y.;Ma, Ma M.-C.;Chen, Chen C.-C.;Chang, H.-H. |
| 臺大學術典藏 |
2021-12-01T06:03:12Z |
Hepatosplenic fungal infection in patients with acute leukemia in Taiwan: Incidence, treatment, and prognosis
|
Chen C.-Y.; YEE-CHUN CHEN; Tang J.-L.; Yao M.; Huang S.-Y.; Tsai W.; YEE-CHUN CHEN; Shen M.-C.; Wang C.-H.; Tien H.-F. |
| 臺大學術典藏 |
2021-12-01T06:03:06Z |
Trends and antimicrobial resistance of pathogens causing bloodstream infections among febrile neutropenic adults with hematological malignancy
|
Chen C.-Y.; Tang J.-L.; Hsueh P.-R.; Yao M.; Huang S.-Y.; YEE-CHUN CHEN; YEE-CHUN CHEN; Shen M.-C.; Wang C.-H.; Tsai W.; Chang S.-C.; Tien H.-F.; Luh K.-T. |
| 臺大學術典藏 |
2021-12-01T02:30:33Z |
Prior invasive fungal infection is not a contraindication for subsequent allogeneic bone marrow transplantation in adult patients with hematologic malignancies [4]
|
Wang J.-T.; Yao M.; Tang J.-L.; Chang S.-C.; CHIEN-CHING HUNG |
| 臺大學術典藏 |
2021-09-04T03:10:22Z |
Crystal-storing histiocytosis in a patient with ocular extranodal marginal zone lymphoma
|
Yu S.-C.; Yao M.; SHU-LANG LIAO |
| 臺大學術典藏 |
2021-09-04T03:10:19Z |
Chemotherapy alone is an alternative treatment in treating localized primary ocular adnexal lymphomas
|
Ma W.-L.; Yao M.; SHU-LANG LIAO; Tang J.-L.; Wang Y.-C.; Kuo S.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2021-09-04T03:10:13Z |
Orbital and ocular adnexal lymphoma: a review of epidemiology and prognostic factors in Taiwan
|
Hsu C.-R.; Chen Y.-Y.; Yao M.; Wei Y.-H.; Hsieh Y.-T.; SHU-LANG LIAO |
| 臺大學術典藏 |
2021-09-01T02:02:46Z |
Clinicopathological spectrum of haemophagocytic syndrome in Epstein-Barr virus-associated peripheral T-cell lymphoma
|
Yao M.; ANN-LII CHENG; Su I.-J.; Lin M.-T.; Uen W.-C.; Tien H.-F.; Wang C.-H.; Chen Y.-C. |
| 臺大學術典藏 |
2021-09-01T01:54:31Z |
Epidemiology of multiple myeloma in Taiwan: Increasing incidence for the past 25 years and higher prevalence of extramedullary myeloma in patients younger than 55 years
|
Huang S.-Y.; Yao M.; Tang J.-L.; Lee W.-C.; Tsay W.; ANN-LII CHENG; Wang C.-H.; Chen Y.-C.; Shen M.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-09-01T01:53:40Z |
Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: A prospective study
|
Hsu C.; Tsou H.-H.; Lin S.-J.; Wang M.-C.; Yao M.; Hwang W.-L.; Kao W.-Y.; Chiu C.-F.; Lin S.-F.; Lin J.; Chang C.-S.; Tien H.-F.; Liu T.-W.; Chen P.-J.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-08-31T06:29:41Z |
Treatment outcomes of and prognostic factors for definitive radiotherapy with and without chemotherapy for Stage I/II nasal extranodal NK/T-cell lymphoma
|
Yang C.W.-C.; Wang C.-W.; Hong R.-L.; Tsai C.-L.; Yao M.; Tang J.-L.; Lin C.-W.; ANN-LII CHENG; Kuo S.-H. |
